Daiichi Sankyo Co.’s edoxaban, the latest in a new group of blood thinners aimed at replacing warfarin, was found to be as effective as the drug that has been the standard of care for 60 years, in a study.
The Canadian Auto Workers is concentrating on negotiations with Ford Motor Co. as the union looks to reach a deal that will set the outlines for agreements with General Motors Co. and Chrysler Group LLC and avoid its first strike against a U.S.-based automaker in 16 years.
Jean Coutu Group Inc., the second- best performing pharmacy stock in North America in the past three years, is poised to buy up smaller rivals as it hoards cash amid consolidation in Canada’s retail industry.
St. Jude Medical Inc.’s Durata lead, the wire used to connect life-saving defibrillators to the heart, proved safe and reliable in an independent review that should ease concerns about its use, researchers said.
Bristol-Myers Squibb Co. and Sanofi- Aventis SA ’s hypertension drug Avapro failed to prevent complications such as heart attacks or lower death rates when given to people with erratic heart rhythms in a trial.
Bristol-Myers Squibb Co. and Pfizer Inc. ended a trial of an experimental blood thinner after a panel found “clear evidence” the drug, apixaban, helped reduce stroke risk in patients with irregular heart beats.
The bacteria responsible for the Black Death that killed a third of Europe’s population from 1347 to 1351 has changed little since then as health and hygiene advances held it in check, scientists said.